Vol. 3 No. 3 (2025): Especial- Octubre- 2025: Revista Multidisciplinaria Investigación Contemporánea
Ciencias de la Salud- Articulo de Revisión

Updating the diagnosis and treatment of RETT syndrome: a systematic review

DOI: 10.58995/redlic.rmic.v3.n3.a164
  • Dennis Raúl Benavides Reinoso
Dennis Raúl Benavides Reinoso
Egresado de la carrera de medicina de la Universidad Católica de Cuenca Campus Azogues

Abstract

Rett syndrome (RS) is an uncommon neurological disorder that affects almost exclusively girls, with an estimated incidence of 1 per 10,000–15,000 live female births. Over 95% of cases are diagnosed in early childhood (6–24 months), presenting with progressive loss of motor, cognitive, and communication abilities, which significantly impacts quality of life and functional prognosis. Objective: To summarize current evidence on diagnostic methods and therapeutic options for RS, aimed at improving the quality of life of pediatric patients. Methods: A systematic review was conducted following PRISMA 2020 guidelines. Articles published between 2019 and 2024 in English and Spanish were included, retrieved from PubMed, Scopus, ScienceDirect, Scielo, Taylor & Francis, Cochrane, and UpToDate. Study quality and risk of bias were assessed using the CASP tool. Results: From 112 initial records, 25 studies were included (22.3%), involving approximately 512 pediatric patients (98% female). Regarding diagnosis, 64% of studies highlighted clinical scales such as the Rett Syndrome Behaviour Questionnaire (RSBQ) and the Clinical Global Impression-Improvement (CGI-I), while 36% emphasized electrophysiological and molecular approaches, including resting EEG and patch-clamp. In treatment, 48% of studies reported ≥40% reduction in seizure frequency with cannabinoids (CBDV, CBD); 28% demonstrated benefits of botulinum toxin for hypersalivation and spasticity; and 24% documented improvements with trofinetide in social communication and adaptive function. Conclusions: Evidence indicates that combining advanced diagnostic tools with emerging therapies (CBDV, CBD, BTX, trofinetide) provides measurable improvements in symptom control and functionality. These findings support the implementation of standardized multimodal protocols, fostering personalized and pediatric-centered management strategies.

articulo completo- pdf (Spanish) articulo completo- html (Spanish) Flipbook (Spanish)

Downloads

Download data is not yet available.

References

  1. Arancibia T, Pardo R, Barrientos P, Arancibia T, Pardo R, Barrientos P. Síndrome de Rett, una mirada actual. Andes pediatrica [Internet]. enero de 2023 [citado 5 de diciembre de 2023];94(1):94-103. Disponible en: http://www.scielo.cl/scielo.php?script=sci_abstract&pid=S2452-60532023000100094&lng=es&nrm=iso&tlng=es DOI: https://doi.org/10.32641/andespediatr.v94i1.4014
  2. Kong Y, Li QB, Yuan ZH, Jiang XF, Zhang GQ, Cheng N, et al. Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation. Front Neurol [Internet]. 2022;13(1):83-6. Disponible en: 10.3389/fneur.2022.838206 DOI: https://doi.org/10.3389/fneur.2022.838206
  3. Liberona AR, Albornoz-Miranda M. Neurobiological Aspects of Rett Syndrome. Revista Chilena de Neuro-Psiquiatria [Internet]. 2023;61(1):107-17. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-92272023000100107 DOI: https://doi.org/10.4067/S0717-92272023000100107
  4. Aron W C, Rauch L G, Benavides G F, Repetto L MG. [Rett Syndrome: MECP2 gene molecular analysis in Chilean patients]. Rev Chil Pediatr [Internet]. abril de 2019;90(2):152-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31095231/ DOI: https://doi.org/10.32641/rchped.v90i2.724
  5. Schultz R, Suter B. Síndrome de Rett: tratamiento y pronóstico. UpToDate [Internet]. noviembre de 2023;1(1):1-10. Disponible en: https://acortar.link/58B46b
  6. Schultz R, Suter B. Síndrome de Rett: genética, características clínicas y diagnóstico. UpToDate [Internet]. noviembre de 2023;1(2):2-20. Disponible en: https://acortar.link/CXhlMO
  7. Haase FD, Coorey B, Riley L, Cantrill LC, Tam PPL, Gold WA. Pre-clinical Investigation of Rett Syndrome Using Human Stem Cell-Based Disease Models. Front Neurosci [Internet]. 2021;15:698812. Disponible en: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.698812/full DOI: https://doi.org/10.3389/fnins.2021.698812
  8. Gomes AR, Fernandes TG, Vaz SH, Silva TP, Bekman EP, Xapelli S, et al. Modeling Rett Syndrome With Human Patient-Specific Forebrain Organoids. Front Cell Dev Biol [Internet]. 2020;8:610427. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758289/ DOI: https://doi.org/10.3389/fcell.2020.610427
  9. Wiedemann A, Renard E, Hernandez M, Dousset B, Brezin F, Lambert L, et al. Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome. Calcif Tissue Int [Internet]. abril de 2019;104(4):355-63. Disponible en: https://link.springer.com/article/10.1007/s00223-018-0505-2 DOI: https://doi.org/10.1007/s00223-018-0505-2
  10. Pérez Brito C. Tratamiento De Fisioterapia En El Síndrome De Rett. 2019 [citado 13 de diciembre de 2023];1(1). Disponible en: https://accedacris.ulpgc.es/jspui/handle/10553/99678
  11. Spagnoli C, Fusco C, Pisani F. Rett Syndrome Spectrum in Monogenic Developmental-Epileptic Encephalopathies and Epilepsies: A Review. Genes (Basel) [Internet]. 28 de julio de 2021;12(8):1157. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10816990/ DOI: https://doi.org/10.3390/genes12081157
  12. Mancipe JA, García SS, Correa JE, Meneses-Echávez JF, González-Jiménez E, Schmidt-RioValle J. Efectividad de las intervenciones educativas realizadas en América Latina para la prevención del sobrepeso y obesidad infantil en niños escolares de 6 a 17 años: una revisión sistemática. Nutrición Hospitalaria. 2015;31(1):102-14.
  13. Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Marsh ED, et al. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat Med. 2023;29(6):1468-75. DOI: https://doi.org/10.1038/s41591-023-02398-1
  14. Keogh C, Pini G, Gemo I, Kaufmann WE, Tropea D. Functional Network Mapping Reveals State-Dependent Response to IGF1 Treatment in Rett Syndrome. Brain Sciences. 2020;10(8):515. DOI: https://doi.org/10.3390/brainsci10080515
  15. Musokhranova U, Grau C, Vergara C, Rodríguez-Pascau L, Xiol C, Castells AA, et al. Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome. J Transl Med. 2023;21(1):756. DOI: https://doi.org/10.1186/s12967-023-04622-5
  16. Cheng H, Du C, Zhang Y, James AF, Dempsey CE, Abdala AP, et al. Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome. Journal of Molecular and Cellular Cardiology. 2019;135:22-30. DOI: https://doi.org/10.1016/j.yjmcc.2019.07.012
  17. Urbinati C, Lanzillotta C, Cosentino L, Valenti D, Quattrini MC, Di Crescenzo L, et al. Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome. Neuropharmacology. 2023;224:109350. DOI: https://doi.org/10.1016/j.neuropharm.2022.109350
  18. Flores J, Natali G, Giorgi J, De Leonibus E, Tongiorgi E. Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes. Experimental Neurology. 2022;353:114056. DOI: https://doi.org/10.1016/j.expneurol.2022.114056
  19. Iglesia P, Cuéllar J, Rodríguez MD. Diagnóstico de Rett. Presentación de un caso. Gaceta Médica Espirituana. 2019;21(1):51-8.
  20. Sysoeva OV, Molholm S, Djukic A, Frey HP, Foxe JJ. Atypical processing of tones and phonemes in Rett Syndrome as biomarkers of disease progression. Transl Psychiatry. 2020;10(1):1-12. DOI: https://doi.org/10.1038/s41398-020-00877-4
  21. Rozensztrauch A, Sebzda A, Śmigiel R. Clinical presentation of Rett syndrome in relation to quality of life and family functioning. J Int Med Res. 2021;49(4):3000605211007714. DOI: https://doi.org/10.1177/03000605211007714
  22. Henriksen MW, Breck H, Sejersted Y, Diseth T, von Tetzchner S, Paus B, et al. Genetic and clinical variations in a Norwegian sample diagnosed with Rett syndrome. Brain Dev. 2020;42(7):484-95. DOI: https://doi.org/10.1016/j.braindev.2020.03.008
  23. Hurley EN, Ellaway CJ, Johnson AM, Truong L, Gordon R, Galettis P, et al. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia. 2022;63(7):1736-47. DOI: https://doi.org/10.1111/epi.17247
  24. Bernardo P, Raiano E, Cappuccio G, Dubbioso R, Bravaccio C, Vergara E, et al. The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications. Neurol Ther. 2019;8(1):155-60. DOI: https://doi.org/10.1007/s40120-018-0125-9
  25. Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Peters SU, et al. Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome. Pediatric Neurology. 2024;152:63-72. DOI: https://doi.org/10.1016/j.pediatrneurol.2023.11.005
  26. Segal EB, Tarquinio D, Miller I, Wheless JW, Dlugos D, Biton V, et al. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia. 2021;62(6):1442-50. DOI: https://doi.org/10.1111/epi.16901
  27. Desnous B, Beretti T, Muller N, Villeneuve N, Daquin G, Lepine A, et al. Efficacy and tolerance of cannabidiol in the epilepsy treatment in patients with Rett syndrome: Experience in a single-center cohort. Clinical Neurophysiology. 2023;150:e149-50. DOI: https://doi.org/10.1016/j.clinph.2023.03.233
  28. Darwish M, Passarell J, Youakim JM, Bradley H, Bishop KM. Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome. Adv Ther. 2024;41(4):1462-80. DOI: https://doi.org/10.1007/s12325-024-02796-y
  29. Vigli D, Cosentino L, Pellas M, De Filippis B. Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome. Neuroscience. 2021;453:113-23. DOI: https://doi.org/10.1016/j.neuroscience.2020.09.041
  30. Romano A, Ippolito E, Favetta M, Lotan M, Moran DS. Individualized Remotely Supervised Motor Activity Programs Promote Rehabilitation Goal Achievement, Motor Functioning, and Physical Activity of People with Rett Syndrome—A Single-Cohort Study. International Journal of Environmental Research and Public Health. 2023;20(1):659. DOI: https://doi.org/10.3390/ijerph20010659
  31. Darwish M, Youakim JM, Harlick J, DeKarske D, Stankovic S. A Phase 1, Open-Label Study to Evaluate the Effects of Food and Evening Dosing on the Pharmacokinetics of Oral Trofinetide in Healthy Adult Subjects. Clin Drug Investig. 1 de junio de 2022;42(6):513-24. DOI: https://doi.org/10.1007/s40261-022-01156-4
  32. Buchanan CB, Stallworth JL, Joy AE, Dixon RE, Scott AE, Beisang AA, et al. Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study. J Neurodevelop Disord. 2022;14(1):31. DOI: https://doi.org/10.1186/s11689-022-09432-2
  33. May D, Ruetsch C, Yang X, Kyle S, Fu C. EPH83 Characteristics, Comorbid Gi Conditions, and Treatment Patterns Among Individuals Diagnosed with Rett Syndrome. Value in Health. 2023;26(6):S179. DOI: https://doi.org/10.1016/j.jval.2023.03.965
  34. Caprì T, Dovigo L, Semino M, Lotan M, Mohammadhasani N, Zamarra G, et al. Use of a low-tech tool in the improvement of social interaction of patients with Rett Syndrome: an observational study. Front Public Health [Internet]. 2024 [citado 3 de junio de 2024];12. Disponible en: https://doi.org/10.3389/fpubh.2024.1353099 DOI: https://doi.org/10.3389/fpubh.2024.1353099
  35. Davis T, Parab P, May DM, Ruetsch C. Understanding Characteristics, Conditions and Treatment Patterns among Males Diagnosed with Rett Syndrome: An Analysis of Commercial Health Insurance Claims. Future Rare Diseases. 2023;3(3):1-12. DOI: https://doi.org/10.2217/frd-2022-0023
  36. Wandin H, Lindberg P, Sonnander K. Development of a tool to assess visual attention in Rett syndrome: a pilot study. Augment Altern Commun. 2020;36(2):118-27. DOI: https://doi.org/10.1080/07434618.2020.1798507
  37. May DM, Neul JL, Satija A, Cheng WY, Lema N, Boca A, et al. Real-world clinical management of individuals with Rett syndrome: a physician survey. J Med Econ. 2023;26(1):1570-80. DOI: https://doi.org/10.1080/13696998.2023.2286778
  38. McPate MJ, Duncan RS, Hancox JC, Witchel HJ. Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. British Journal of Pharmacology. 2008;155(6):957-66. DOI: https://doi.org/10.1038/bjp.2008.325
  39. Percy AK, Lane J, Annese F, Warren H, Skinner SA, Neul JL. When Rett syndrome is due to genes other than MECP2. Transl Sci Rare Dis. 2018;3(1):49-53. DOI: https://doi.org/10.3233/TRD-180021
  40. Mandell DS, Wiggins LD, Carpenter LA, Daniels J, DiGuiseppi C, Durkin MS, et al. Racial/ethnic disparities in the identification of children with autism spectrum disorders. Am J Public Health. 2019;99(3):493-8. DOI: https://doi.org/10.2105/AJPH.2007.131243
  41. Reza Suárez L, Rodríguez Mallea RJ, Plaza Avilés CA, Mena Avilés SA. Trastornos del espectro autista: síndrome de Rett y su repercusión en el rendimiento académico. Atlante Cuadernos de Educación y Desarrollo [Internet]. 29 de diciembre de 2018 [citado 21 de octubre de 2024];1(diciembre). Disponible en: https://www.eumed.net/rev/atlante/2018/12/sindromerett-rendimiento-academico.html?fb_comment_id=1907178066047966_2267260586706377
  42. Fajardo KAM, Álvarez DES, Zambrano VPP. Perfil epidemiológico del autismo en Latinoamérica: Morocho Kate, Sánchez Doménica, Viviana Patiño. Salud & Ciencias Medicas [Internet]. 30 de diciembre de 2021 [citado 23 de octubre de 2024];1(2):14-25. Disponible en: https://saludycienciasmedicas.uleam.edu.ec/index.php/salud/article/view/25
  43. Chamba C, Clerque AE, Ontaneda-Cordero K, Romero-Ochoa MG. Síndrome de Asperger desde una visión socioeducativa en la pandemia en Ecuador. AXIOMA [Internet]. 29 de junio de 2022 [citado 23 de octubre de 2024];(26):52-9. Disponible en: https://axioma.pucesi.edu.ec/index.php/axioma/article/view/730 DOI: https://doi.org/10.26621/ra.v1i26.730
  44. Ortiz JBM, Párraga VSA. Síndrome de Rett: epidemiologia, diagnóstico clínico y complicaciones en la mortalidad infantil. Revista Investigación y Educación en Salud [Internet]. 25 de diciembre de 2023 [citado 23 de octubre de 2024];2(2):70-82. Disponible en: https://revistas.unesum.edu.ec/salud/index.php/revista/article/view/32
  45. Hurley EN, Ellaway CJ, Johnson AM, Truong L, Gordon R, Galettis P, et al. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia. julio de 2022;63(7):1736-47. DOI: https://doi.org/10.1111/epi.17247
  46. Pini G, Scusa MF, Benincasa A, Bottiglioni I, Congiu L, Vadhatpour C, et al. Repeated Insulin-Like Growth Factor 1 Treatment in a Patient with Rett Syndrome: A Single Case Study. Front Pediatr [Internet]. 3 de junio de 2014 [citado 11 de septiembre de 2025];2. Disponible en: https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2014.00052/full DOI: https://doi.org/10.3389/fped.2014.00052
  47. Di Pierro D, Ciaccio C, Sbardella D, Tundo GR, Bernardini R, Curatolo P, et al. Effects of oral administration of common antioxidant supplements on the energy metabolism of red blood cells. Attenuation of oxidative stress-induced changes in Rett syndrome erythrocytes by CoQ10. Mol Cell Biochem [Internet]. enero de 2020;463(1-2):101-13. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31595423/ DOI: https://doi.org/10.1007/s11010-019-03633-5
  48. D’Onofrio G, Kuchenbuch M, Hachon-Le Camus C, Desnous B, Staath V, Napuri S, et al. Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study. Front Neurol [Internet]. 2020;11:829. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32903409/ DOI: https://doi.org/10.3389/fneur.2020.00829
  49. Dale T, Downs J, Wong K, Leonard H. The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder. Epilepsy Behav [Internet]. septiembre de 2021;122:108152. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34148781/ DOI: https://doi.org/10.1016/j.yebeh.2021.108152
  50. Grayson L, Ampah S, Hernando K, Kankirawatana P, Gaston T, Cutter G, et al. Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy. Epilepsy Behav [Internet]. septiembre de 2021;122:108190. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34273739/ DOI: https://doi.org/10.1016/j.yebeh.2021.108190
  51. Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, et al. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review. Behav Neurol [Internet]. 2023;2023:8825358. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37868743/ DOI: https://doi.org/10.1155/2023/8825358
  52. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry [Internet]. marzo de 2015;56(3):345-65. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25649325/ DOI: https://doi.org/10.1111/jcpp.12381
  53. Campos NS, Arens CM, Ovares NS. Actualización en crup viral para médicos de atención primaria. Revista Ciencia y Salud Integrando Conocimientos [Internet]. 1 de junio de 2020 [citado 19 de abril de 2024];4(3):ág. 2-11. Disponible en: https://revistacienciaysalud.ac.cr/ojs/index.php/cienciaysalud/article/view/126 DOI: https://doi.org/10.34192/cienciaysalud.v4i3.126
  54. Fu C, Armstrong D, Marsh E, Lieberman D, Motil K, Witt R, et al. Multisystem comorbidities in classic Rett syndrome: a scoping review. BMJ Paediatr Open [Internet]. 22 de septiembre de 2020 [citado 19 de diciembre de 2023];4(1):731. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509967/ DOI: https://doi.org/10.1136/bmjpo-2020-000731
  55. Meyer C, Grenness C, Scarinci N, Hickson L. What Is the International Classification of Functioning, Disability and Health and Why Is It Relevant to Audiology? Semin Hear [Internet]. agosto de 2016;37(3):163-86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27489397/ DOI: https://doi.org/10.1055/s-0036-1584412
articulo completo- pdf (Spanish) articulo completo- html (Spanish) Flipbook (Spanish)

Published 2025-10-01

Keywords

  • diagnosis,
  • rett syndrome,
  • cell therapy,
  • treatment

Issue

Vol. 3 No. 3 (2025): Especial- Octubre- 2025: Revista Multidisciplinaria Investigación Contemporánea

Section

Ciencias de la Salud- Articulo de Revisión

Copyright (c) 2025 Los autores que publiquen en la revista Multidisciplinaria Investigación Contemporánea aceptan los siguientes términos: 1. Los autores mantienen sus derechos de autor (copyright) y otorgan a la revista Multidisciplinaria Investigación Contemporánea el derecho de la primera publicación de su trabajo, bajo una licencia Creative Commons Attribution 4.0. Esta licencia permite que terceros utilicen el contenido publicado, siempre que se mencione la autoría y la primera publicación en esta revista. 2. Los autores pueden establecer acuerdos adicionales para la distribución no exclusiva de la versión publicada de su artículo en otros lugares, como repositorios institucionales, siempre y cuando se indique claramente que el trabajo fue publicado por primera vez en esta revista. 3. Los autores conservan sus derechos de autor (copyright) y garantizan a la revista Multidisciplinaria Investigación Contemporánea el derecho a publicar el manuscrito a través de los canales que considere apropiados. 4. Se permite y se recomienda a los autores compartir su trabajo en línea (por ejemplo, en repositorios institucionales o páginas web personales), una vez que el manuscrito haya sido aceptado para su publicación. Esto puede conducir a intercambios productivos y a una mayor y más rápida citación del trabajo publicado. Detalle de Licencia CC BY (https://creativecommons.org/licenses/by/4.0/) Usted es libre de: Compartir — copiar y redistribuir el material en cualquier medio o formato para cualquier propósito, incluso comercialmente. Adaptar — remezclar, transformar y construir a partir del material para cualquier propósito, incluso comercialmente. La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia Bajo los siguientes términos: Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios . Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante. No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Benavides Reinoso , D. R. . (2025). Updating the diagnosis and treatment of RETT syndrome: a systematic review. Contemporary Research, 3(3). https://doi.org/10.58995/redlic.rmic.v3.n3.a164
Crossref
Scopus
Google Scholar
Europe PMC

Similar Articles

You may also start an advanced similarity search for this article.